ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Glucosanol in Maintaining Body Weight
To date, there is no clinical evidence on the efficacy and safety of Glucosanol in maintaining weight loss beyond the study duration of 12 weeks. The rationale for this open-label study is to assess the efficacy in preventing regain of loss body weight and safety of Glucosanol in subjects who are overweight or obese over a longer period after the initial weight loss.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Glucosanol™ in Reducing Post-prandial Glucose Levels in Overweight Subjects#969062
- Persistent Weight Maintenance for 6 Months After 3 Months of Active Weight Loss#855173
- Gdue Plus a Hypocaloric Mediterranean Diet in Adults With MASLD#1088704
- A Study on the Effect of Bariatric Surgery on Glucose Metabolism in Chinese Obese and Type 2 Diabetes Patients#1340452
- Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity#143722
Record · ID 1378331
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive